1. Home
  2. FGEN vs BATL Comparison

FGEN vs BATL Comparison

Compare FGEN & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • BATL
  • Stock Information
  • Founded
  • FGEN 1993
  • BATL 1987
  • Country
  • FGEN United States
  • BATL United States
  • Employees
  • FGEN N/A
  • BATL N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • BATL Oil & Gas Production
  • Sector
  • FGEN Health Care
  • BATL Energy
  • Exchange
  • FGEN Nasdaq
  • BATL Nasdaq
  • Market Cap
  • FGEN 34.5M
  • BATL 29.9M
  • IPO Year
  • FGEN 2014
  • BATL N/A
  • Fundamental
  • Price
  • FGEN $0.71
  • BATL $1.62
  • Analyst Decision
  • FGEN Strong Buy
  • BATL
  • Analyst Count
  • FGEN 1
  • BATL 0
  • Target Price
  • FGEN $10.00
  • BATL N/A
  • AVG Volume (30 Days)
  • FGEN 7.2M
  • BATL 62.7K
  • Earning Date
  • FGEN 03-04-2025
  • BATL 03-28-2025
  • Dividend Yield
  • FGEN N/A
  • BATL N/A
  • EPS Growth
  • FGEN N/A
  • BATL N/A
  • EPS
  • FGEN N/A
  • BATL N/A
  • Revenue
  • FGEN $180,015,000.00
  • BATL $191,482,000.00
  • Revenue This Year
  • FGEN $21.91
  • BATL $2.21
  • Revenue Next Year
  • FGEN N/A
  • BATL N/A
  • P/E Ratio
  • FGEN N/A
  • BATL N/A
  • Revenue Growth
  • FGEN 16.15
  • BATL N/A
  • 52 Week Low
  • FGEN $0.18
  • BATL $1.31
  • 52 Week High
  • FGEN $2.80
  • BATL $7.08
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 65.95
  • BATL 39.04
  • Support Level
  • FGEN $0.54
  • BATL $1.63
  • Resistance Level
  • FGEN $0.88
  • BATL $1.77
  • Average True Range (ATR)
  • FGEN 0.07
  • BATL 0.14
  • MACD
  • FGEN 0.02
  • BATL 0.02
  • Stochastic Oscillator
  • FGEN 59.79
  • BATL 3.61

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.

Share on Social Networks: